Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2002 2
2003 1
2007 1
2010 1
2011 2
2012 3
2013 14
2014 15
2015 14
2016 8
2017 8
2018 10
2019 5
2020 9
2021 23
2022 30
2023 25
2024 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: roque dm. J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27. J Clin Oncol. 2018. PMID: 29584549 Clinical Trial.
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers S, Secord AA, Havrilesky L, O'Malley DM, Backes FJ, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi K, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: roque dm. Clin Cancer Res. 2020 Aug 1;26(15):3928-3935. doi: 10.1158/1078-0432.CCR-20-0953. Epub 2020 Jun 29. Clin Cancer Res. 2020. PMID: 32601075 Free PMC article. Clinical Trial.
Race and Ethnicity Reporting and Representation in Obstetrics and Gynecology Clinical Trials and Publications From 2007-2020.
Steinberg JR, Turner BE, DiTosto JD, Weeks BT, Young AMP, Lu CF, Wolgemuth T, Holder K, Laasiri N, Squires N, Zhang N, Richardson MT, Magnani CJ, Anderson JN, Roque DR, Yee LM. Steinberg JR, et al. Among authors: roque dr. JAMA Surg. 2023 Feb 1;158(2):181-190. doi: 10.1001/jamasurg.2022.6600. JAMA Surg. 2023. PMID: 36542396 Free PMC article.
Nanoparticle-Based Treatment in Glioblastoma.
Roque D, Cruz N, Ferreira HA, Reis CP, Matela N, Herculano-Carvalho M, Cascão R, Faria CC. Roque D, et al. J Pers Med. 2023 Aug 29;13(9):1328. doi: 10.3390/jpm13091328. J Pers Med. 2023. PMID: 37763096 Free PMC article. Review.
Tubulin Complexity in Cancer and Metastasis.
Danziger M, Xu F, Noble H, Yang P, Roque DM. Danziger M, et al. Among authors: roque dm. Adv Exp Med Biol. 2024;1452:21-35. doi: 10.1007/978-3-031-58311-7_2. Adv Exp Med Biol. 2024. PMID: 38805123 Review.
Healthcare Disparities in Gynecologic Oncology.
Grubbs A, Barber EL, Roque DR. Grubbs A, et al. Among authors: roque dr. Adv Oncol. 2022 May;2(1):119-128. doi: 10.1016/j.yao.2022.02.003. Epub 2022 May 4. Adv Oncol. 2022. PMID: 35669851 Free PMC article. No abstract available.
Review of Immune Therapies Targeting Ovarian Cancer.
Fan CA, Reader J, Roque DM. Fan CA, et al. Among authors: roque dm. Curr Treat Options Oncol. 2018 Nov 14;19(12):74. doi: 10.1007/s11864-018-0584-3. Curr Treat Options Oncol. 2018. PMID: 30430276 Review.
Microtentacle Formation in Ovarian Carcinoma.
Reader JC, Fan C, Ory EC, Ju J, Lee R, Vitolo MI, Smith P, Wu S, Ching MMN, Asiedu EB, Jewell CM, Rao GG, Fulton A, Webb TJ, Yang P, Santin AD, Huang HC, Martin SS, Roque DM. Reader JC, et al. Among authors: roque dm. Cancers (Basel). 2022 Feb 4;14(3):800. doi: 10.3390/cancers14030800. Cancers (Basel). 2022. PMID: 35159067 Free PMC article.
The Role of Eicosanoids in Gynecological Malignancies.
Smith PG, Roque D, Ching MM, Fulton A, Rao G, Reader JC. Smith PG, et al. Among authors: roque d. Front Pharmacol. 2020 Aug 26;11:1233. doi: 10.3389/fphar.2020.01233. eCollection 2020. Front Pharmacol. 2020. PMID: 32982722 Free PMC article. Review.
170 results